BRAF and colorectal cancer: reported that the proposed CT-based radiomics signature is associated with KRAS/NRAS/BRAF mutations; their study indicated that CT may be useful for the analysis of tumor genotype in colorectal cancer and thus helpful to determine therapeutic strategies (39).